WYNNVISION, LLC

Medtech · Private

Amine gradient-functionalized silicone ventricular catheter for ventriculoperitoneal shunts that resists bacterial infection and cell adhesion

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Total capital: $4.6M

Federal grants: $4.6M; 8 awards · 2017–2025; Rank in peer group#181 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 7 pending · first 2023; Rank in peer group#237 of 538

Capital timeline

Latest events

Sep 2025Federal grantHealth and Human S · Phase II · Reducing infections and blockage associated with long-term implantation of ventriculoperitoneal and related shunts$306K
May 2024Federal grantHealth and Human S · Phase II · Toward urinary catheterization with long-term resistance to bacterial colonization$540K
Apr 2023Federal grantHealth and Human S · Phase II · Toward urinary catheterization with long-term resistance to bacterial colonization$515K
May 2020Federal grantHealth and Human S · Phase II · Antimicrobial and Biocompatible Endotracheal Tubes$786K
May 2019Federal grantHealth and Human S · Phase II · Antimicrobial and Biocompatible Endotracheal Tubes$709K
Aug 2018Federal grantHealth and Human S · Phase II · Antimicrobial and Biocompatible Endotracheal Tubes$225K
Sep 2017Federal grantHealth and Human S · Phase II · Antimicrobial catheters with cell and tissue compatibility$821K

Show 1 earlier federal award

Mar 2017Federal grantHealth and Human S · Phase II · Antimicrobial catheters with cell and tissue compatibility$670K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#181 · top 34%
Granted patents#237 · top 44%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 8

Apr 18, 2024PendingAmtimicrobial SiliconesUSPTOApplication 18201709
Jun 6, 2023GrantedAmtimicrobial SiliconesUSPTOUS 11,666,686
PendingAntimicrobial SiliconesUSPTOApplication 63618260

Show all 8 patent records

Amtimicrobial SiliconesApr 18, 2024 · Application 18201709Pending
Amtimicrobial SiliconesJun 6, 2023 · US 11,666,686Granted
Antimicrobial SiliconesApplication 63618260Pending
Antimicrobial SiliconesApplication 63068947Pending
Antiviral SiliconesApplication 63014102Pending
Compositions Of Matter, That Have Antimicrobial Properties, Mixtures, And Methods To Make And Use ThemApplication 18881558Pending
Antimicrobial SiliconesApplication 62962922Pending
Compositions Of Matter, That Have Antimicrobial Properties, Mixtures, And Methods To Make And Use ThemApplication 63738804Pending

FITOTO TECHNOLOGIES INC.Similar federal contract value in Medtech · null in contracts
Alio, Inc.Similar federal contract value in Medtech · null in contracts
Trugenomix Health, Inc.Similar federal contract value in Medtech · null in contracts
UNPLUGS HEARING, INC.Similar federal contract value in Medtech · null in contracts
ENTRATYMPANIC, LLCSimilar federal contract value in Medtech · null in contracts
QUANTUM DESIGN, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.